18-46507526-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001384474.1(LOXHD1):​c.5692+12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 1,551,298 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 24 hom. )

Consequence

LOXHD1
NM_001384474.1 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -3.09

Publications

1 publications found
Variant links:
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
LOXHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 77
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Fuchs' endothelial dystrophy
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-46507526-C-T is Benign according to our data. Variant chr18-46507526-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 178394.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00188 (2629/1399002) while in subpopulation MID AF = 0.0302 (172/5694). AF 95% confidence interval is 0.0265. There are 24 homozygotes in GnomAdExome4. There are 1376 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOXHD1NM_001384474.1 linkc.5692+12G>A intron_variant Intron 36 of 40 ENST00000642948.1 NP_001371403.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LOXHD1ENST00000642948.1 linkc.5692+12G>A intron_variant Intron 36 of 40 NM_001384474.1 ENSP00000496347.1 A0A2R8Y7K4

Frequencies

GnomAD3 genomes
AF:
0.00149
AC:
227
AN:
152178
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00332
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.00132
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00329
AC:
513
AN:
156014
AF XY:
0.00335
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.00490
Gnomad ASJ exome
AF:
0.0127
Gnomad EAS exome
AF:
0.0000918
Gnomad FIN exome
AF:
0.000119
Gnomad NFE exome
AF:
0.00216
Gnomad OTH exome
AF:
0.00616
GnomAD4 exome
AF:
0.00188
AC:
2629
AN:
1399002
Hom.:
24
Cov.:
31
AF XY:
0.00199
AC XY:
1376
AN XY:
690002
show subpopulations
African (AFR)
AF:
0.00120
AC:
38
AN:
31592
American (AMR)
AF:
0.00541
AC:
193
AN:
35690
Ashkenazi Jewish (ASJ)
AF:
0.0109
AC:
275
AN:
25162
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35710
South Asian (SAS)
AF:
0.00567
AC:
449
AN:
79222
European-Finnish (FIN)
AF:
0.0000203
AC:
1
AN:
49222
Middle Eastern (MID)
AF:
0.0302
AC:
172
AN:
5694
European-Non Finnish (NFE)
AF:
0.00118
AC:
1276
AN:
1078736
Other (OTH)
AF:
0.00386
AC:
224
AN:
57974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
135
269
404
538
673
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00148
AC:
226
AN:
152296
Hom.:
0
Cov.:
33
AF XY:
0.00154
AC XY:
115
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41560
American (AMR)
AF:
0.00373
AC:
57
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00894
AC:
31
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00132
AC:
90
AN:
68020
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00210
Hom.:
0
Bravo
AF:
0.00214
Asia WGS
AF:
0.00462
AC:
16
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 16, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

5506+12G>A in Intron 35 of LOXHD1: This variant is not expected to have clinical significance because it is not located within the conserved splice consensus se quence and has been identified in 0.6% (48/7914) of South Asian chromosomes incl uding 1 homozygote, and in 0.6% (50/3710) of European chromosomes by the Exome A ggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs200518261). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 77 Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.037
DANN
Benign
0.63
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200518261; hg19: chr18-44087489; API